Clinicopatholgical and Molecular Features Associated With Programmed Cell Death Ligand 1 (PD-L1) Expression in Resected Lung Squamous Cell Carcinomas

被引：0
|
作者：
Huynh, Tiffany [1 ]
Chi, Anthony [1 ]
Uruga, Hironori [1 ]
Bozkurtlar, Emine [1 ]
Mark, Eugene [1 ]
Mino-Kenudson, Mari [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1916
引用
收藏
页码：478A / 478A
页数：1
相关论文
共 50 条
  • [31] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Kotaro Matsuda
    Hiroaki Miyoshi
    Koji Hiraoka
    Tetsuya Hamada
    Shiro Yoshida
    Yukinao Ishibashi
    Toshiaki Haraguchi
    Naoto Shiba
    Koichi Ohshima
    Clinical and Experimental Medicine, 2018, 18 : 487 - 494
  • [32] Programmed Death Ligand 1 Expression in Laryngeal Squamous Cell Carcinomas and Prognosis
    Batur, Sebnem
    Kain, Zeynep Ecem
    Gozen, Emine Deniz
    Kepil, Nuray
    Aydin, Ovgu
    Comunoglu, Nil
    CLINICAL PATHOLOGY, 2020, 13
  • [33] Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Expression Patterns in Ewing and Ewing-Like Sarcoma
    Tamura, A.
    Yoshida, M.
    Yamamoto, N.
    Nakamura, S.
    Fujiwara, T.
    Tahara, T.
    Saito, A.
    Kozaki, A.
    Kishimoto, K.
    Ishida, T.
    Hasegawa, D.
    Kosaka, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S336 - S336
  • [34] Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas
    Spurny, Christian
    Kailayangiri, Sareetha
    Jamitzky, Silke
    Altvater, Bianca
    Wardelmann, Eva
    Dirksen, Uta
    Hardes, Jendrik
    Hartmann, Wolfgang
    Rossig, Claudia
    PEDIATRIC BLOOD & CANCER, 2018, 65 (01)
  • [35] The significance of programmed cell death ligand 1 expression in resected lung adenocarcinoma
    Wu, Shafei
    Shi, Xiaohua
    Sun, Jian
    Liu, Yuanyuan
    Luo, Yufeng
    Liang, Zhiyong
    Wang, Jinghui
    Zeng, Xuan
    ONCOTARGET, 2017, 8 (10) : 16421 - 16429
  • [36] Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinoma
    Serra, Pierre
    Petat, Arthur
    Maury, Jean-Michel
    Thivolet-Bejui, Francoise
    Chalabreysse, Lara
    Barritault, Marc
    Ebran, Nathalie
    Milano, Gerard
    Girard, Nicolas
    Brevet, Marie
    LUNG CANCER, 2018, 118 : 62 - 68
  • [37] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Neelima Vidula
    Christina Yau
    Hope S. Rugo
    Breast Cancer Research and Treatment, 2021, 187 : 387 - 395
  • [38] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [39] PROGRAMMED DEATH-LIGAND (PD-L1) EXPRESSION AND LYMPH NODE INVOLVEMENT IN PENILE SQUAMOUS CELL CARCINOMA
    Peyroteo, Ines
    Santos, Filipa
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1010 - E1011
  • [40] COMBINED PROGRAMMED CELL DEATH LIGAND 1 (PD-L1)/CD8 EXPRESSION IN GRADE 3 ENDOMETRIAL CARCINOMAS
    Vagios, S.
    Yiannou, P.
    Giannikaki, E.
    Doulgeraki, T.
    Papadimitriou, C.
    Rodolakis, A.
    Nonni, A.
    Vlachos, A.
    Pavlakis, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A373 - A373
12345